2022
DOI: 10.1515/cclm-2021-1331
|View full text |Cite
|
Sign up to set email alerts
|

Monocyte distribution width (MDW) as a screening tool for early detecting sepsis: a systematic review and meta-analysis

Abstract: Objectives Monocyte distribution has recently emerged as a promising biomarker of sepsis, especially in acute setting, such as Emergency Department and Intensive Care Unit. This study aimed to evaluate the accuracy of monocyte distribution width (MDW) for early detecting patients with sepsis by performing a systemic review and meta-analysis of published studies. Methods Relevant publications were identified by a systematic li… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 27 publications
(19 citation statements)
references
References 28 publications
(20 reference statements)
2
17
0
Order By: Relevance
“…We further compared these in vitro modifications to those measured in COVID-19 and Sepsis patients. The cut-offs reported for both MDW index and histone values are in agreement with literature references (healthy control subjects [5,6,11,12,15]; COVID-19 patients [12,14,15]; and Sepsis patients [5,6,11]).…”
Section: Introductionsupporting
confidence: 89%
See 2 more Smart Citations
“…We further compared these in vitro modifications to those measured in COVID-19 and Sepsis patients. The cut-offs reported for both MDW index and histone values are in agreement with literature references (healthy control subjects [5,6,11,12,15]; COVID-19 patients [12,14,15]; and Sepsis patients [5,6,11]).…”
Section: Introductionsupporting
confidence: 89%
“…Among common laboratory biomarkers shared by SARS-CoV-2 and Sepsis infections [7,11], the modification of the hematological parameter Monocyte Distribution Width (MDW) predicts both multiorgan failure and increased mortality rate in Sepsis conditions [11]. MDW index (FDA-approved, EC-marked early Sepsis indicator of monocyte heterogeneity upon massive inflammatory activation [11]) is further recognized as diagnostic/prognostic marker for COVID-19 severity and clinical outcomes, as a kind of novel viral Sepsis biomarker [12][13][14].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, the SOFA score can take time to obtain; thus, SIRS criteria [abnormal white blood cell count (WBC), tachycardia, tachypnea, and fever (or hypothermia)] and quick sepsis-related organ failure assessment (qSOFA) score (tachypnea, altered mental state, and hypotension) are used as surrogate methods to assist in the quick diagnosis of sepsis in the ED. Crouser et al 33 found that regardless of SIRS or qSOFA variables, an initial MDW >20.0% (vs. <20.0) significantly increased the incidence of sepsis; Meanwhile, according to Agnello et al 34 meta-analysis data, MDW plays an important role in Sepsis screening regardless of the Sepsis-2 and Sepsis-3 standard groups; therefore, MDW improved the early detection of sepsis in the initial ED and was a good complement to SIRS and qSOFA parameters. Similarly, the combination of MDW and white blood cell count (WBC), 35 neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) 36 significantly improved the early diagnosis of sepsis.…”
Section: Introductionmentioning
confidence: 99%
“…[ 13 ] After infectious stimuli, monocytes undergo activation leading to functional and morphological changes. [ 14 ] Presepsin, a 13-kDa protein and a fragment of monocyte LPS receptor CD14, is released in the blood circulation by proinflammatory signals during infection and has diagnostic and prognostic values in sepsis. [ 15 , 16 ] Here, we explored the usefulness of MDW and presepsin for early assessment of disease severity in COVID-19 patients.…”
Section: Introductionmentioning
confidence: 99%